Select Page
This news article is related to:
This news article is related to:
Achievement of a PROACTIVE maturity level
National Agency of Drug and Food Control
2019

October 1, 2019, 07.32 pm

Appreciation from the POM RI for Proactively Implementing Government Provisions

Dexa Group’s commitment to support government programs through the implementation of regulations and policies in the pharmaceutical sector has received appreciation from the Indonesian POM. The Head of the POM RI, Mrs. Penny Lukito, presented the award to the CEO of Dexa Group, Mr. Ferry Soetikno, for the role of PT Ferron Par Pharmaceuticals as a pharmaceutical industry with the achievement of a PROACTIVE maturity level in activities to increase the participation of business actors in implementing applicable regulations.

The appreciation from the POM RI took place at a socialization event, a consultation desk, and a training activity entitled “Regulatory Assistance to Increase Competitiveness in the Pharmaceutical and National Economy”, at Arya Duta Hotel Bandung, West Java on Monday, September 23, 2019. The event attended by around 500 participants consisting of the Pharmaceutical Industry and Pharmaceutical Wholesalers (PBF) in the Greater Jakarta, Serang, and West Java areas. In addition to the CEO of Dexa Group, Mr. Ferry Soetikno, he was also present to accompany the Director of Operations of PT Ferron Par Pharmaceuticals, Mr. Benny Sutisna Suwarno.

‚ÄúThis award is a form of Dexa Group’s commitment to continue to serve in accordance with its core purpose, Expertise for the Promotion of Health. This award is also a form of Dexa Group’s support for the Indonesian government’s program, in this case the RI POM,” said Ferry Soetikno.

Furthermore, Mr. Ferry invites all Dexans to continue their commitment in making people healthy, serving the nation, by supporting various government work programs that aim to benefit customers and the community. The real proof of the commitment of Ferron and Dexa Group to support the government’s recent program is the obtaining of the Halal Assurance System Status from LPPOM-MUI with the Very Good category. In addition, Dexa Group, including Ferron, also supports the POM RI in increasing the effectiveness of drug control to prevent the circulation of counterfeit drugs through the implementation of a serialization system with 2D barcodes in product packaging.

In her speech, Ms. Penny Lukito said that in order to increase the competitiveness of the Indonesian pharmaceutical industry, pharmaceutical industry players are expected to increase their awareness and understanding of applicable regulations and standards, which are in line with the POM Agency’s priority on the development of superior human resources in the health sector.

For this reason, according to Ms. Penny Lukito, Drug and Food Control is a comprehensive system (full spectrum or life cycle process) covering the entire process cycle, from the beginning of the process of a product before it is distributed (pre-market) to as long as the product is circulating in the community ( post-market).

“In an effort to guarantee the safety of drugs to be circulated, the POM Agency evaluates the safety, efficacy, and quality of drugs before obtaining distribution permits. The POM Agency also conducts post-market supervision to ensure that the products circulating in the market comply with the applicable regulations,” he said.

The comprehensive drug control process is the same as that carried out by other countries in ensuring the safety of drugs being circulated. With regulations and requirements related to safety, efficacy, and quality that must be met, it is intended that the resulting medicinal products meet the requirements for distribution in the country as well as for export purposes.

Currently, according to Mrs. Penny, the POM Agency is accelerating the licensing and certification process for CPOB and CDOB by simplifying it through reducing re-registration, online application systems, and implementing 2D barcodes. This is in accordance with Presidential Instruction Number 6 of 2016 concerning the Acceleration of the Development of the Pharmaceutical and Medical Devices Industry.

“In carrying out drug and food supervision, the POM cannot run alone. The synergistic role of all components of the nation starting from the government, stakeholders/business actors to the community is very much needed in efforts to protect the community. The challenge ahead is that innovation is needed in strengthening drug and food control through partnerships. For that, let’s jointly oversee the safety, efficacy, and quality of medicines and food circulating in Indonesia as a real contribution in ensuring the quality of life of the Indonesian people is guaranteed,” concluded the Head of the POM Agency.